When Could the FDA Approve a Moderna Vaccine?

Nov.16 -- Moderna Inc. said its Covid-19 vaccine was 94.5% effective in a preliminary analysis of a large late-stage clinical trial. The company is now expected to apply for emergency authorization from the FDA. Bloomberg's Drew Armstrong reports on "Bloomberg Surveillance."